B
BC Platforms
A global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice
About BC Platforms
BC Platforms specializes in genomic data management solutions aimed at advancing precision medicine and research. The company integrates clinical and genetic data to provide actionable insights for healthcare providers, research institutions, and pharmaceutical companies. Operating in the global healthcare and biotechnology markets, BC Platforms employs a subscription-based business model, offering its software as a service (SaaS). Revenue is generated through licensing fees, data analytics services, and partnerships with research organizations. The company serves a diverse clientele, including hospitals, universities, and biotech firms, helping them to leverage big data for improved patient outcomes and innovative research.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 1997
- Headquarters
- Zurich, Switzerland
- Employees
- 107
- Open positions
- 3
- Dealroom signal
- 60.9/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Analytics, Data Analytics, Biotechnology, Genetics and genomics, Precision Medicine, Spinout, Biotech and Pharma, AI Drug Discovery, Techbio
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 2 companies, latest Dec 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VC✓Equity / VC | Nov 2022 | $20M | — | Jolt Capital | ↗ |
| SERIES C✓Equity / VC | Dec 2019 | $15M | $60M | Debiopharm Group · Tesi · IQVIA | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for BC Platforms is 4K monthly website visits, down 50% over the last three months. BC Platforms's team declined 18.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
MedexprimLabège, FranceReal-World Evidence for better Care
→
4PharmaTurku, Finland a contract research organization (CRO) providing medical research services to pharmaceutical, biotechnology, medical device and food companies.
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Debiopharm Group
Tesi
Series B and later2 investors entered at this stage
IQVIA
Jolt Capital
Other known investors3 additional known investors
- BPBoston Millennia Partners
MIT Sloan School of Management
StartAngels
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BC Platforms on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BC Platforms’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.